Impaired visual recognition memory in amnestic mild cognitive impairment is associated with mesiotemporal metabolic

Mira Didic1, Jean-Philippe Ranjeva, Emmanuel Barbeau

  • 1Service de Neurologie et de Neuropsychologie, Pôle de neurosciences cliniques, Assistance Publique des Hôpitaux de Marseille, Hôpitaux de la Timone, CMRR PACA Ouest & INSERM U751, Faculté de Médecine, Université de la Méditerranée, Marseille, France. mira.didic@ap-hm.fr

Insights

Impaired visual recognition memory (VRM) in mild cognitive impairment is linked to metabolic changes in the mesial temporal lobe (MTL). This VRM test may help predict Alzheimer

Area of Science:

  • Neuroscience
  • Biochemistry
  • Medical Imaging

Background:

  • Early Alzheimer's disease (AD) involves neurofibrillary tangles in the mesial temporal lobe (MTL), affecting visual recognition memory (VRM).
  • Amnestic mild cognitive impairment (aMCI) patients often exhibit VRM deficits, suggesting early neuropathological changes.
  • Metabolic alterations in the MTL are implicated in AD progression, but their direct link to VRM impairment needs further investigation.

Purpose of the Study:

  • To investigate the association between VRM impairment and metabolic changes in the MTL in aMCI patients using magnetic resonance spectroscopic imaging (MRSI).
  • To assess the potential of VRM evaluation as an early diagnostic tool for Alzheimer's disease (AD).
  • To correlate metabolic markers in the MTL with VRM performance and predict future conversion to AD.

Main Methods:

  • 28 aMCI patients and 28 controls underwent comprehensive neuropsychological assessment, including VRM evaluation using the DMS48 test.
  • Magnetic resonance spectroscopic imaging (MRSI) was employed to measure N-acetylaspartate/myo-inositol (NAA/mIno) ratios in the MTL.
  • aMCI patients were subgrouped based on VRM performance; metabolic data were analyzed in relation to VRM scores and clinical follow-up.

Main Results:

  • aMCI patients exhibited reduced NAA/mIno ratios in the right hippocampus compared to controls.
  • aMCI patients with impaired VRM showed significantly decreased bilateral MTL NAA/mIno ratios, including the anterior subhippocampal cortex.
  • DMS48 performance correlated with NAA/mIno levels in the anterior MTL, and impaired VRM predicted conversion to AD with 81.8% accuracy over 6 years.

Conclusions:

  • Impaired VRM in aMCI is associated with specific metabolic reductions in the MTL, particularly the anterior subhippocampal cortex.
  • VRM deficits serve as a key indicator of MTL dysfunction and may represent an early hallmark of Alzheimer's disease.
  • The DMS48 test, by evaluating VRM, shows promise as a predictive tool for early AD diagnosis and monitoring disease progression.